Ethnicity and sex modify the association of serum C-reactive protein with microalbuminuria

Ethnicity and Disease

Volumn 18, Issue 3, 2008, Pages 324-329

  Palmas, Walter ^a   Shuangge, Ma ^c   Jacobs Jr , David R ^d,e   Arnett, Donna ^f   Jackson, Sharon ^g   Olson, Jean ^h   Saad, Mohammed F ⁱ   Kronmal, Richard ^c   Kramer, Holly ^j   Barr, R Graham ^a,b,k  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b University of Washington ^*  (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ STONY BROOK UNIVERSITY   (United States)

^j LOYOLA UNIVERSITY CHICAGO   (United States)

^k Division of General Medicine   (United States)

more..

Author keywords

Albuminuria; C reactive protein; Ethnicity; Sex

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; ALBUMINURIA; ATHEROSCLEROSIS; BLOOD; BLOOD PRESSURE; CAUCASIAN; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; ETHNIC GROUP; ETHNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; STATISTICS;

AGED; ALBUMINURIA; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS;

EID: 55249106489     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. MacLeod JM, Lutale J, Marshall SM. Albumin excretion and vascular deaths in NIDDM. Diabetologia. 1995;38:610-616.
2. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ. 1996;313:779-784.
3. Ljungman S, Wikstrand J, Hartford M, Berglund G. Urinary albumin excretion-a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens. 1996;9:770-778.
4. Donnelly R, Yeung JM, Manning G. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. J Hypertens. 2003;21(SuppI 1):S7-12.
5. Arnlov J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969-975.
6. Rodby RA, Rohde RD, Sharon Z, Pohl MA, Bain RP, Lewis EJ. The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in rype 1 diabetic patients with nephropathy. The Collaborative Study Group. Am J Kidney Dis. 1995:26:904-909.
7. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens. 1998;16:1325-1333.
8. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and ptevention. Circulation. 2003; 107:363-369.
9. Ridket PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.
10. Fried L, Solomon C, Shlipak M, et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004; 15:3184-3191.
11. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005;68:237-245.
12. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study. Kidney Int. 2000:58:1703-1710.
13. Nakamura M, Onoda T, Itai K, et al. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med. 2004;43:919-925.
14. Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, De Pergola G. Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J Intern Med. 2001;250:502-507.
15. Saraheimo M, Tcppo AM, Forsblom C, FageruddJ, Groop PH. Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients. Diabetologia. 2003;46:1402-1407.
16. Jager A, van Hinsbergh VW, Kostense PJ, et al. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vase Biol. 2002;22:593-598.
17. Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005;46:464-469.
18. Lakoski SG, Cushman M, Criqui M, et al. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J. 2006;152:593-598.
19. Jacobs DRJr, Murtaugh MA, Steffes M, YuX, Roseman J, Goetz FC. Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol. 2002,155: 111 4-1119.
20. Matrix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and ace. J Am Soc Nephrol. 2002:13:1034-1039.
21. Rutter MK, Meigs JB, Sullivan LM, D'Agos-tino RBSr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004;110:380-385.
22. Makita S, Nakamura M, Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke. 2005:36:2138-2142.
23. Wang TJ, Nam BH, Wilson PW, et al. Association of C-reactive protein with catotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vase Biol. 2002;22:1662-1667.
24. Stuveling EM, Bakker SJ, Hillege HL, et al. C- reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension. 2004;43:791-796.
25. Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002; 156:871-881.
26. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol. 1992;45:683-692.
27. Kramer H, Jacobs DR Jr, Bild D, et al. Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension. 2005;46:38-43.
28. Bautista LE. Associations of microalbuminuria with inflammation markers in hypertensive men. Am J Hypertens. 2006;19:467.
29. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
30. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
31. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902-2907.
32. Gillum RF. Stroke in Blacks. Stroke. 1988:19:1-9.
33. Mehta RH, Marks D, Califf RM, et al. Differences in the clinical features and outcomes in African Americans and Whites with myocardial infarction. Am J Med. 2006;119(70):el-8.
34. Sharma S, Malarcher AM, Giles WH, Myers G. Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors. Ethn Dis. 2004;14:43-48.
35. Sytkowski PA, D'Agostino RB, Belanger A, Kannel WB. Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol. 1996;143:338-350.
36. Verhave JC, Hillege HL, Burgerhof JG, Navis G, de Zeeuw D, de Jong PE. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol. 2003;14:1330-1335.